A palliative accelerated irradiation regimen for advanced non–small-cell lung cancer VS. conventionally fractionated 60 GY: results of a randomized equivalence study

This publication has 24 references indexed in Scilit:

• Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer
  British Journal of Cancer, 1998
• CHARTWEL-Bronchus (ARO 97-1)
  Strahlentherapie und Onkologie, 1997
• Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer
  Radiotherapy and Oncology, 1997
• Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial
  The Lancet, 1997
• Dose escalation for non-small cell lung cancer using conformal radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1997
• The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995
• Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis
  Cancer, 1995
• A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status
  British Journal of Cancer, 1992
• Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions
  British Journal of Cancer, 1991